• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


3.9500 USD 0.00000.00%

As of 20:10:00 ET on 06/25/2014.

Snapshot for Zeltia SA (ZLIXF)

Open: - Day's Range: - Volume: 200
Previous Close: 3.9500 52wk Range: 2.9600 - 3.9500 1-Yr Rtn: -

Stock Chart for ZLIXF

No chart data available.
  • ZLIXF:US 3.9500
  • 1D
  • 1M
  • 1Y
Interactive ZLIXF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZLIXF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 28.4683
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 0.1020
Est. PEG Ratio -
Market Cap (M USD) 877.71
Shares Outstanding (M) 222.20
30 Day Average Volume 7
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 07/15/2011
5 Year Dividend Growth -
Next Earnings Announcement 07/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZLIXF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ZLIXF

Zeltia, S.A. is a holding composed of biotechnological and chemical companies. The Company's main activity is developing marine derived anti-cancer drugs and CNS pathologies treatments. Zeltia's other activities include developing diagnosis kits and RNAi technology based therapeutical applications.

Jose Maria Fernandez Sousa-FaroChairmanPedro Francisco Fernandez PuentesVice Chairman
Maria Luisa De Francia CaballeroChief Financial OfficerJose Luis Moreno Martinez-LosaDir:Capital Market
More Company Profile & Key Executives for ZLIXF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil